Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    18322686 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed PS-341 and Doxorubicin in Treating Patients With Advanced Solid Tumors
Condition: Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: bortezomib;   Drug: doxorubicin hydrochloride

Indicates status has not been verified in more than two years